Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

PACB

STRONG SELL

Pacific Biosciences of California, Inc. · Healthcare · United States · $422M · Avg Vol: $9M/d

6
StockRank
Get insider-trade alerts
Q
19
V
25
M
32
P/E (TTM)
—
ROE
-273.6%
D/E
298.6x
Dividend %
—
Dir. Trades · 180d
−$120.8K →
Buybacks · 180d
None →

COMPANY DESCRIPTION

Pacific Biosciences of California, Inc. develops and markets advanced DNA sequencing systems utilizing its proprietary Single Molecule, Real-Time (SMRT) technology. The company holds a strong position in the long-read sequencing market, providing high-fidelity data essential for complex genomic research and clinical applications. Its innovative technology offers a competitive moat by enabling more comprehensive analysis compared to traditional short-read methods.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue128.3M200.5M154.0M160.0M7.6%160.0M167.4M194.3M10.2%
EPS-1.40-1.21-1.12-1.82—-0.39-0.51-0.39—
Shares226.5M267.7M294.4M302.0M+33.3%310.6M———
Debt948.5M933.9M672.4M702.4M-9.5%706.4M———
Equity562.9M701.3M506.6M5.3M-78.8%————
Op CF-263.2M-259.2M-206.1M-111.2M—-111.8M———
Inv CF116.1M4.6M124.0M115.4M—————
Fin CF9.6M108.9M-43.0M3.4M—————
Loading 1Y...
PRICE (1Y)+3.8%
1.311.421.521.631.74Jun 12Jul 7Jul 27
SMA 50SMA 200
Close
$1.36
RSI (14)
33.9
52W High
$2.73
From 52W High
0.5%

SCORE BREAKDOWN

Quality
19
ROIC
-75.8%8.9
ROE
-273.6%2.9
GP/Assets
7.8%23.4
Op. Margin
-102.9%17.3
FCF/Assets
-6.2%33.7
Piotroski
316.0
Int. Cover
-50.0x6.3
D/E Ratio
298.56x0.0
Current Ratio
5.65x74.1
Value
25
P/E (TTM)
—N/A
EV/EBITDA
-6.0x25.0
P/FCF
—N/A
P/B
170.0x0.5
P/S
2.6x59.8
Div Yield
—N/A
Momentum
32
52W High %
50%25.9
RS 6M
-55%11.3
SMA 50/200
0.84x25.8
EPS Rev 4W
+0.1%76.3
EPS Rev 12W
+5.1%78.5
EPS Improve
-2%20.6
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$422M
P/E (Forward)
-3.4x
Gross Margin
38.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PACB are excluded.

TickerCompanyMkt CapStockRankSignal
PACBPacific Biosciences of California, Inc.(you)$422M6STRONG SELL
MOBIMobia Medical, Inc.$361M7STRONG SELL
CLPTClearPoint Neuro, Inc.$423M13STRONG SELL
IMR.AXImricor Medical Systems, Inc.$455M15STRONG SELL
SENSSenseonics Holdings, Inc.$254M4STRONG SELL
CATXPerspective Therapeutics, Inc.$332M16STRONG SELL
CVCapsoVision, Inc.$324M17STRONG SELL
LUCDLucid Diagnostics Inc.$173M7STRONG SELL
TLSITriSalus Life Sciences, Inc.$259M16STRONG SELL
LABStandard BioTools Inc.$326M22SELL

Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.6%

Pacific Biosciences of California, Inc. (PACB) — Stock Score Summary

Pacific Biosciences of California, Inc. (PACB) has a MoatMap StockRank of 6/100 based on Quality (19/100), Value (25/100), and Momentum (32/100) factor scores. The current signal is STRONG SELL.

Pacific Biosciences of California, Inc. develops and markets advanced DNA sequencing systems utilizing its proprietary Single Molecule, Real-Time (SMRT) technology. The company holds a strong position in the long-read sequencing market, providing high-fidelity data essential for complex genomic research and clinical applications. Its innovative technology offers a competitive moat by enabling more comprehensive analysis compared to traditional short-read methods.

Key Financial Metrics

Price$1.36
Market Cap$422M
P/E (Forward)-3.43
Price/Book170.00
Return on Equity-273.6%
Return on Invested Capital-75.8%
Debt/Equity298.56x
Gross Margin38.3%
Operating Margin-102.9%
Revenue Growth0.1%
Free Cash Flow$-48M

Pacific Biosciences of California, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Pacific Biosciences of California, Inc.’s (PACB) StockRank?
MoatMap’s StockRank for Pacific Biosciences of California, Inc. (PACB) is 6/100, with a Strong Sell signal. It is a composite of Quality (19), Value (25), and Momentum (32) factor ranks across MoatMap’s 20,000+ stock universe.
Does Pacific Biosciences of California, Inc. have an economic moat?
Pacific Biosciences of California, Inc. (PACB) has a Quality factor score of 19/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Pacific Biosciences of California, Inc. a buy, hold, or sell?
MoatMap’s current signal for Pacific Biosciences of California, Inc. (PACB) is Strong Sell, based on a StockRank of 6/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Pacific Biosciences of California, Inc. in?
Pacific Biosciences of California, Inc. (PACB) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksPACB deep dive reportAI ChampionsHow we score stocksSense-check another stock